Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial

Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0; the study record remains inaccessible due to a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T02:05:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice appears above the page stating that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:04:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:53:34.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:29:41.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The ROMANA 3 study page now shows a 403 error and the detailed study content has been removed, leaving only navigation and footer information.
    Difference
    15%
    Check dated 2026-09-20T00:57:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study locations in Israel were updated. Qiryat Krinitzi was removed and Tel Litwinsky was added.
    Difference
    0.0%
    Check dated 2026-09-12T23:47:29.000Z thumbnail image

Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.